Citing people involved in the effort, The New York Times reported on Tuesday evening that the FDA was speeding up its approval process as the country faces a new wave of infections from the more contagious delta variant.
There has been increasing pressure on the FDA to give full approval for the vaccine, which was urgently approved last year. Some proponents of the vaccine have cited the lack of full approval as a reason for avoiding the vaccine, and it is hoped that the approval will build public confidence and encourage more people to get the vaccine.
requested full approval on May 7 and fellow vaccine maker Moderna Inc. MRNA,
asked the same in June.
Full approval is a much more in-depth type of authorization that takes longer; even a “priority review” can take six months. But experts have urged the FDA to speed up the process, as COVID-19 continues to spread and the vaccine has been proven to be safe and effective in millions of people.